Search Our Scientific Publications & Authors

Int J Health Serv 2011 ;41(2):231-8

Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkin University, Baltimore, MD 21205, USA.

Neurology 2008 Jul;71(1):21-7

Economic Research Service, US Department of Agriculture, 1800 M Street, N.W., Washington, DC 20036-5831, USA.

Objective: This study estimated the annual economic cost of Guillain-Barré syndrome (GBS) in the United States in 2004, including the direct costs of medical care and the indirect costs due to lost productivity and premature death.

Methods: The cost-of-illness method was used to determine the costs of medical care and lost productivity, and a modified value of a statistical life approach was used to determine the cost of premature deaths. Data were obtained from the Nationwide Inpatient Sample, the Medical Expenditure Panel Survey, the Compressed Mortality File, a telephone survey of 180 adult patients with GBS, and other sources. Read More

Diabetes Care 2003 Mar;26(3):917-32

Lewin Group, Inc, Falls Church, Virginia, USA.

Objective: Diabetes is the fifth leading cause of death by disease in the U.S. Diabetes also contributes to higher rates of morbidity-people with diabetes are at higher risk for heart disease, blindness, kidney failure, extremity amputations, and other chronic conditions. Read More

Arch Intern Med 2009 Mar;169(5):493-501

Section of General Internal Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.

Background: Racial and ethnic minorities generally receive fewer medical interventions than whites, but racial and ethnic patterns in Medicare expenditures and interventions may be quite different at life's end.

Methods: Based on a random, stratified sample of Medicare decedents (N = 158 780) in 2001, we used regression to relate differences in age, sex, cause of death, total morbidity burden, geography, life-sustaining interventions (eg, ventilators), and hospice to racial and ethnic differences in Medicare expenditures in the last 6 months of life.

Results: In the final 6 months of life, costs for whites average $20,166; blacks, $26,704 (32% more); and Hispanics, $31,702 (57% more). Read More

JAMA 1996 Nov;276(18):1473-9

Institute for Health and Aging at the University of California, San Francisco, USA.

Objectives: To determine (1) the number and proportion of Americans living with chronic conditions, and (2) the magnitude of their costs, including direct costs (annual personal health expenditures) and indirect costs to society (lost productivity due to chronic conditions and premature death).

Design: Analysis of the 1987 National Medical Expenditure Survey for prevalence and direct health care costs; indirect costs based on the 1990 National Health Interview Survey and Vital Statistics of the United States.

Setting: US population. Read More